292 related articles for article (PubMed ID: 28265817)
1. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
Huang YC; Huang YW; Lin YT; Wang FD; Chan YJ; Yang TC
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1373-1380. PubMed ID: 28265817
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
Huang YC; Lin YT; Wang FD
Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006.
Hsu MS; Liao CH; Huang YT; Liu CY; Yang CJ; Kao KL; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1271-8. PubMed ID: 21461847
[TBL] [Abstract][Full Text] [Related]
4. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
6. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality.
Lau SK; Chow WN; Foo CH; Curreem SO; Lo GC; Teng JL; Chen JH; Ng RH; Wu AK; Cheung IY; Chau SK; Lung DC; Lee RA; Tse CW; Fung KS; Que TL; Woo PC
Sci Rep; 2016 May; 6():26045. PubMed ID: 27185741
[TBL] [Abstract][Full Text] [Related]
7. Infections due to Elizabethkingia meningoseptica in critically injured trauma patients: a seven-year study.
Rastogi N; Mathur P; Bindra A; Goyal K; Sokhal N; Kumar S; Sagar S; Aggarwal R; Soni KD; Tandon V
J Hosp Infect; 2016 Jan; 92(1):30-2. PubMed ID: 26763750
[TBL] [Abstract][Full Text] [Related]
8. Identification and epidemiological relatedness of clinical Elizabethkingia meningoseptica isolates from central Taiwan.
Chang YC; Lo HH; Hsieh HY; Chang SM
J Microbiol Immunol Infect; 2014 Aug; 47(4):318-23. PubMed ID: 23726463
[TBL] [Abstract][Full Text] [Related]
9. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections.
Jean SS; Lee WS; Chen FL; Ou TY; Hsueh PR
J Hosp Infect; 2014 Apr; 86(4):244-9. PubMed ID: 24680187
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
Chou DW; Wu SL; Lee CT; Tai FT; Yu WL
Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014.
Lee MR; Tsai CJ; Liang SK; Lin CK; Huang YT; Hsueh PR
Int J Antimicrob Agents; 2015 Oct; 46(4):439-45. PubMed ID: 26298673
[TBL] [Abstract][Full Text] [Related]
12. Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Jean SS; Hsieh TC; Ning YZ; Hsueh PR
Int J Antimicrob Agents; 2017 Oct; 50(4):507-511. PubMed ID: 28705672
[TBL] [Abstract][Full Text] [Related]
13. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics.
Mirza HC; Tuncer Ö; Ölmez S; Şener B; Tuğcu GD; Özçelik U; Gürsoy NC; Otlu B; Büyükçam A; Kara A; Sancak B
Microb Drug Resist; 2018; 24(6):816-821. PubMed ID: 29227188
[TBL] [Abstract][Full Text] [Related]
14. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.
Chen FL; Wang GC; Teng SO; Ou TY; Yu FL; Lee WS
J Microbiol Immunol Infect; 2013 Dec; 46(6):425-32. PubMed ID: 23022462
[TBL] [Abstract][Full Text] [Related]
15. Waterborne Elizabethkingia meningoseptica in Adult Critical Care.
Moore LS; Owens DS; Jepson A; Turton JF; Ashworth S; Donaldson H; Holmes AH
Emerg Infect Dis; 2016 Jan; 22(1):9-17. PubMed ID: 26690562
[TBL] [Abstract][Full Text] [Related]
16. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality.
Hung PP; Lin YH; Lin CF; Liu MF; Shi ZY
J Microbiol Immunol Infect; 2008 Apr; 41(2):137-44. PubMed ID: 18473101
[TBL] [Abstract][Full Text] [Related]
17. Multicentre study evaluating matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility.
Cheng YH; Perng CL; Jian MJ; Cheng YH; Lee SY; Sun JR; Shang HS
Clin Microbiol Infect; 2019 Mar; 25(3):340-345. PubMed ID: 29689427
[TBL] [Abstract][Full Text] [Related]
18. Relative Prevalence and Antimicrobial Susceptibility of Clinical Isolates of Elizabethkingia Species Based on 16S rRNA Gene Sequencing.
Han MS; Kim H; Lee Y; Kim M; Ku NS; Choi JY; Yong D; Jeong SH; Lee K; Chong Y
J Clin Microbiol; 2017 Jan; 55(1):274-280. PubMed ID: 27847376
[TBL] [Abstract][Full Text] [Related]
19. A study of antibiotic and disinfectant susceptibility of Elizabethkingia meningoseptica.
Kanashenko ME; Mitzevich IP; Kartsev NN; Astashkin EI; Detusheva EV; Khramov MV; Svetoch EA; Fursova NK
Klin Lab Diagn; 2021 Apr; 66(4):242-247. PubMed ID: 33878247
[TBL] [Abstract][Full Text] [Related]
20. A Rare Case of Elizabethkingia meningoseptica Bacteremia After Liver Transplantation.
Hoa LTV; Dang Hai P
Am J Case Rep; 2021 Nov; 22():e933992. PubMed ID: 34799546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
